Search - tctmd.com

Displaying 61 - 80 of 970

Sort: Relevancy | Date

News Daily News

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Michael O'Riordan

May 09, 2023

News Daily News

Cath Lab Garbage: ‘What Are We Going to Do About It?’

Michael O'Riordan

May 08, 2023

News Daily News

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Shelley Wood

April 14, 2023

News Daily News

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Michael O'Riordan

March 31, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Conference News ACC 2023

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Michael O'Riordan

March 06, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Conference News CRT 2023

‘Beeting’ In-stent Restenosis? Dietary Nitrate May Improve Outcomes

Yael L. Maxwell

February 27, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

SCAI Updates Position on Doing PCI Without Surgical Backup

Michael O'Riordan

February 20, 2023

News Daily News

Top Coronary Artery Disease News of 2022

Yael L. Maxwell

December 29, 2022

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Todd Neale

November 21, 2022

News Daily News

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Yael L. Maxwell

November 21, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Shelley Wood

November 06, 2022

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Todd Neale

September 22, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Conference News ESC 2022

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Todd Neale

August 29, 2022

Advertisement

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Cath Lab Garbage: ‘What Are We Going to Do About It?’

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

March 2023 News Roundup

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

‘Beeting’ In-stent Restenosis? Dietary Nitrate May Improve Outcomes

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

SCAI Updates Position on Doing PCI Without Surgical Backup

Top Coronary Artery Disease News of 2022

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Many STEMI Patients Not Treated Within National Time Goals

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content